OTCM
GALNF
Market cap5.34bUSD
Nov 23, Last price
75.25USD
Name
Galenica AG
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Galenica AG, a Bern, Switzerland-based company founded in 1927, functions as a prominent healthcare service provider, operating across Switzerland and on an international scale. Its comprehensive operations are strategically divided into two primary segments: Products & Care, and Logistics & IT. Within the Products & Care division, Galenica manages an extensive network of 520 pharmacies, comprising 368 directly owned outlets and 152 partner locations. These operate under established brand names such as Amavita, Sun Store, and Coop Vitality. Beyond retail pharmacy management, this segment is also responsible for delivering medication for at-home patient treatment, launching and distributing a diverse portfolio of consumer health, pharmaceutical, and parapharmaceutical products, and providing dedicated marketing and sales assistance to its healthcare industry collaborators. The Logistics & IT segment delivers a suite of specialized pre-wholesale services to pharmaceutical and other healthcare enterprises. These offerings encompass storage, efficient distribution, and debt collection. Furthermore, this division provides broader logistics and IT infrastructure, including a master data system specifically designed for the healthcare sector. It also focuses on developing sophisticated management solutions for the healthcare market and is responsible for publishing both digital and print technical information about pharmaceutical products, in addition to offering comprehensive management platforms for pharmacies.
Key people
Independent Chairman of the Board of Directors · since 2023
Marc Werner
Chief Executive Officer, Member of the Corporate Executive Committee · since 2021
Independent Vice Chairwoman of the Board of Directors · since 2023
Julian Fiessinger
Chief Financial Officer, Member of the Corporate Executive Committee · since 2025
Lukas Ackermann
Chief IT & Digital Business, Member of the Corporate Executive Committee · since 2024
Arianne Hasler
Chief People and Culture Officer, Member of the Corporate Executive Committee · since 2023
Virginie Jeschka
Chief Pharmacies Officer, Member of the Corporate Executive Committee · since 2021
Andreas Koch
Chief Wholesale & Logistics, Member of the Corporate Executive Committee · since 2021
Daniele Madonna
Chief Pharmacies Category Management & Health Services, Member of the Corporate Executive Committee · since 2024
Stephan Mignot
Chief Pharmacies Marketing, Member of the Corporate Executive Committee · since 2024
Thomas Szuran
Chief Products & Home Care, Deputy Chief Executive Officer, Member of the Corporate Executive Committee · since 2025
Barbara Walchli
General Secretary · since 2020
Nadine Balkanyi-Nordmann
Independent Member of the Board of Directors · since 2025
Bertrand Jungo
Independent Member of the Board of Directors · since 2023
Judith Meier
Independent Member of the Board of Directors · since 2022
Solange Peters
Independent Member of the Board of Directors · since 2023
Joerg Zulauf
Independent Member of the Board of Directors · since 2023
Headquarters & legal address
Untermattweg 8
Bern, BE 3027
CH
Bern, BE 3027
CH
Other language
Galenica Ltd.
Other language
Galenica SA
Valuation
Title CHF in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||